Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference86 articles.
1. Global cancer incidence and mortality rates and trends—an update;Torre;Cancer Epidemiol Biomarkers Prev,2016
2. Cancer statistics, 2010;Jemal;CA A Cancer J Clin,2010
3. Comparison of four chemotherapy regimens for advanced non–small-cell lung cancer;Schiller;N Engl J Med,2002
4. American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non–small-cell lung cancer;Azzoli;J Clin Oncol,2009
5. Molecular pathology of lung cancer: key to personalized medicine;Cheng;Mod Pathol,2012
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ROS1 kinase inhibition reimagined: identifying repurposed drug via virtual screening and molecular dynamics simulations for cancer therapeutics;Frontiers in Chemistry;2024-07-29
2. PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC);International Journal of Molecular Sciences;2024-07-17
3. Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway;Biomedicine & Pharmacotherapy;2024-07
4. Physiologically driven nanodrug delivery system for targeted lung cancer treatment;Exploration of Medicine;2024-04-25
5. Multitask learning approach for lung nodule segmentation and classification in CT images;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3